Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05250349 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT05250349 · ClinicalTrials.gov record · last posted 2022-02-22

TRAnscranial Doppler CErebral Blood Flow and Cognitive IMPAIRment in Heart Failure

Name: TRAnscranial Doppler CErebral Blood Flow and Cognitive IMPAIRment in Heart Failure — clinical trial record (NCT05250349)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TRACE-IMPAIR

StatusRecruiting

PhaseNot specified

SponsorJohn Paul II Hospital, Krakow

Started2021-09-01

View on ClinicalTrials.gov ↗

Record status

This record was last updated February 22, 2022 (before its estimated September 1, 2022 completion). Its status may not reflect the trial's current state.

from the ClinicalTrials.gov record

TRACE-IMPAIR is a prospective, clinical study of consecutive patients that evaluates the relationship between heart failure (HF) and cognitive impairment in relation to carotid and cerebral flow. The carotid and cerebral flow will be assessed using Doppler ultrasonography, and cognitive function will be estimated during routine neuropsychological tests. It is an observational, three(natural)-group, single-center study. It is also an Academic Registry - the scientific activity of the Faculty of Medicine, Collegium Medicum, Jagiellonian University, and John Paul II Hospital.

Trial Details

NCT Number	NCT05250349
Lead Sponsor	John Paul II Hospital, Krakow
Conditions	Heart Failure, Cognitive Impairment, Carotid Stenosis
Enrollment	300 participants
Start Date	2021-09-01
Primary Completion	2022-09-01 (estimated)
Study Completion	2027-09-01 (estimated)
Updated on ClinicalTrials.gov	2022-02-22